PROMETHEUS BIOSCIENCES, INC. General and Administrative Expense
PROMETHEUS BIOSCIENCES, INC. reported General and Administrative Expense of $13.39 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for the quarter ending 2023-03-31 was $13.39M, a 65.64% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for the quarter ending 2022-12-31 was $12.04M, a 62.34% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for the quarter ending 2022-09-30 was $10.27M, a 0.23% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for the quarter ending 2022-06-30 was $9.32M, a 65.88% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for fiscal 2022 was $39.74M, a 39.41% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for fiscal 2021 was $28.50M, a 157.06% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. general and administrative expense for fiscal 2020 was $11.09M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-03-31 | $13.39M 10-Q · filed 2023-05-09 | $25.43M derived: sum of 2 quarters · filed 2023-05-09 | $35.70M derived: sum of 3 quarters · filed 2023-05-09 | $45.02M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $12.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $22.31M derived: sum of 2 quarters · filed 2023-02-28 | $31.63M derived: sum of 3 quarters · filed 2023-02-28 | $39.74M 10-K · filed 2023-02-28 |
| 2022-09-30 | $10.27M 10-Q · filed 2022-11-09 | $19.59M derived: sum of 2 quarters · filed 2022-11-09 | $27.70M 10-Q · filed 2022-11-09 | $35.09M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $9.32M 10-Q · filed 2022-08-11 | $17.41M 10-Q · filed 2022-08-11 | $24.82M derived: sum of 3 quarters · filed 2023-05-09 | $35.07M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $8.09M 10-Q · filed 2023-05-09 | $15.50M derived: sum of 2 quarters · filed 2023-05-09 | $25.75M derived: sum of 3 quarters · filed 2023-05-09 | $31.37M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $17.66M derived: sum of 2 quarters · filed 2023-02-28 | $23.28M derived: sum of 3 quarters · filed 2023-02-28 | $28.50M 10-K · filed 2023-02-28 |
| 2021-09-30 | $10.25M 10-Q · filed 2022-11-09 | $15.87M derived: sum of 2 quarters · filed 2022-11-09 | $21.09M 10-Q · filed 2022-11-09 | $24.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $5.62M 10-Q · filed 2022-08-11 | $10.84M 10-Q · filed 2022-08-11 | $14.56M derived: sum of 3 quarters · filed 2023-02-28 | $17.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $5.22M 10-Q · filed 2022-05-12 | $8.94M derived: sum of 2 quarters · filed 2023-02-28 | $12.11M derived: sum of 3 quarters · filed 2023-02-28 | $13.92M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.89M derived: sum of 2 quarters · filed 2023-02-28 | $8.70M derived: sum of 3 quarters · filed 2023-02-28 | $11.09M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.17M 10-Q · filed 2021-11-12 | $4.98M derived: sum of 2 quarters · filed 2021-11-12 | $7.37M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.81M 10-Q · filed 2021-08-11 | $4.20M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $2.39M 10-Q · filed 2021-05-13 |